Skip to main content
. 2019 Nov 5;9:1177. doi: 10.3389/fonc.2019.01177

Figure 2.

Figure 2

Growth factor levels before treatment, at 7 weeks after start of treatment, 3 months and 1 year after termination of treatment in patients with head and neck cancer. *, **Statistically significant. EGF, epidermal growth factor; FGF-2, fibroblast growth factor 2; VEGF, vascular endothelial growth factor.